Foot News and Research

RSS

BioMimetic granted Canadian notice of patent allowance covering rhPDGF-BB platform technology formulations

BioMimetic Therapeutics, Inc. announced today the Canadian Intellectual Property Office (CIPO) has allowed patent application No. 2,583,823 titled "Platelet Derived Growth Factor (PDGF) Compositions and Methods of Use Thereof". The new patent will remain in force until October 2025, during which time it will prohibit the marketing of similar or generic versions of the Company's Augment™ orthopedic product line and certain other rhPDGF-BB product formulations.

17 Dec 2010

RAD to restore SCI's Radiation Treatment Center

Swedish Cancer Institute (SCI) has embarked on a bold approach to rapidly restore community-based radiotherapy cancer treatment in the Ballard community utilizing state-of-the-art building technology that is swift and green.

16 Dec 2010

Oxygen Biotherapeutics and SMP sign Binding Letter of Intent for joint chronic ischemic wound research

Oxygen Biotherapeutics, Inc. and privately held Sarasota Medical Products, Inc. (SMP) of Sarasota, FL, today announced they signed a Binding Letter of Intent to determine the feasibility of pursuing a joint research and development venture for treating chronic ischemic wounds. The venture will be based on combining Oxygen's Wundecyte™ PFC formulation with SMP's topical medical devices.

16 Dec 2010

Study finds that immobilization devices significantly reduce braking response time

Patients recovering from a right foot injury or surgery should think twice about how soon they want to begin driving again. According to a new study from the Journal of Bone and Joint Surgery (JBJS), it takes much longer to brake when the driver is wearing an immobilization device - like a splint or brace, than it does when wearing normal footwear.

16 Dec 2010

Synergetics launches next generation of Codman Malis electrosurgical generator

Synergetics USA, Inc., a medical device company that designs, manufactures, and markets innovative products for ophthalmic and neurosurgical applications, has introduced the CMC® V, the next generation of the Codman® Malis® electrosurgical generator. Codman & Shurtleff, Inc. is the exclusive distributor of the CMC® V. CMC and Codman are registered trademarks of Johnson & Johnson Corporation.

15 Dec 2010

SunOpta subsidiary closes acquisition of Edner

SunOpta Inc. today announced that its indirect wholly-owned subsidiary SunOpta Fruit Group Inc. has completed the previously announced acquisition of the assets and business of Edner of Nevada, Inc..

14 Dec 2010

Natural Prosthetic Dental Lab launches 'Digital revolution of dentistry'

News briefs concerning economic and business growth in the Tampa Bay region from the Tampa Bay Partnership:

14 Dec 2010

Cannabis Science signs lease for new corporate headquarters in Denver, Colorado

Cannabis Science, Inc. a pioneering U.S. biotech company developing pharmaceutical cannabis products, is pleased to announce it has signed a lease for a new corporate headquarters as its new base of operations in Denver, Colorado. The 6,600 sq. ft. core facility at 2422 S. Trenton Way, Unit H will be dedicated to housing executive offices, administrative personnel, as well as the Lab Division core of operations for its cannabis formulations testing and FDA initiatives.

14 Dec 2010

ACCESS receives $6.7M NIH Clinical and Translational Science Award

Access Community Health Network (ACCESS) has received a $6.7 million Clinical and Translational Science Award grant from the National Institutes of Health (NIH) to construct a community-based research center. The goal of the center's research will be to engage the community and reduce racial and ethnic disparities in health care.

14 Dec 2010

Research programs embody the promise of anti-aging medicine.

Sometimes the value of research lies as much in exposing false remedies as in discovering true breakthroughs. Scientists at the country's first school of gerontology and in laboratories around the University of Southern California do both, mindful of their responsibility to a society focused on healthful aging.

13 Dec 2010

MMI-USA announces limited launch of new Smart Toe II Hammertoe Fixation System

MMI-USA, a subsidiary of Memometal Technologies S.A., a global orthopaedic manufacturer headquartered in France, announces the limited launch of the new Smart Toe® II Hammertoe Fixation System. The product becomes an important piece of a comprehensive system for forefoot fixation, and reinforces the most widely used franchise of intramedullary implants of this kind in the world.

10 Dec 2010

DPT granted FDA approval to manufacture Collagenase SANTYL Ointment for wound care

DPT Laboratories, Ltd., a pharmaceutical contract development and manufacturing organization, announced today that it received FDA approval to manufacture commercial supplies of a leading sterile ointment for wound care at its Center of Excellence for Sterile & Specialty Products in Lakewood, N.J. Beginning this month, Healthpoint will ship commercial lots of Collagenase SANTYL® Ointment produced at DPT's Lakewood facility to its North American customers.

9 Dec 2010

Researchers synthesize wound-healing peptides

Newly-created bioactive peptides promote wound healing through the growth of new blood vessels and epithelial tissue, such as skin. These wound-healing peptides, synthesized by researchers at the Tufts Center for Innovations in Wound Healing Research, increased angiogenesis in vitro by 200 percent.

8 Dec 2010

32% of UAE residents could have diabetes or prediabetes by 2020

One in three United Arab Emirates (UAE) residents could have diabetes or prediabetes by the end of the decade, according to a new analysis from international health and well-being company UnitedHealth Group, released today at the World Health Care Congress Middle East meeting in Abu Dhabi.

7 Dec 2010

Third Edition of Occupational Medicine Practice Guidelines released

The American College of Occupational and Environmental Medicine (ACOEM) has released the Third Edition of Occupational Medicine Practice Guidelines to subscribers of the guideline development and content publishing platform, APG-I. The proprietary, evidence-based system provides full access to ACOEM's complete guidelines, featuring thousands of pages of the most current evidence medical treatment recommendations.

7 Dec 2010

New brain imaging technique can trace effects of SYN115 drug in Parkinson's disease

Neuroscientists using a new brain imaging technique could see an investigational drug for Parkinson's disease get into a patient's brain and affect blood flow in several key structures, an indicator the drug may be effective.

1 Dec 2010

Rush University enrolls first U.S. patient in international clinical trial for melanoma

Rush University Medical Center has just enrolled the first U.S. patient in an international clinical trial testing a novel drug to treat certain kinds of melanoma, a deadly skin cancer that in its advanced stages currently has few effective treatments.

1 Dec 2010

Methodist to develop national training center for treatment of cardiovascular disease

The Methodist DeBakey Heart & Vascular Center recently received a generous gift to develop a national training center for surgical and interventional treatments for cardiovascular disease, the number one killer of Americans. The benefactor wishes to remain anonymous.

30 Nov 2010

University Hospitals receives $42 million for cancer care

Jane and Lee Seidman have donated $42 million to University Hospitals (UH) the largest gift in the Cleveland-based health system's history. In recognition of this unprecedented generosity, UH is naming the "Jane and Lee Seidman Cancer Center" in their honor.

30 Nov 2010

Sante to break ground on second and third post hospital stay rehabilitation centers

Sante Partners announces that they will officially break ground on their second and third post hospital stay rehabilitation centers: Sante of Surprise and Sante of Chandler on Wednesday, December 1st at 9 a.m. and Wednesday, December 1st at 1 p.m. respectively. The facilities will be dedicated to servicing patients/guests in the prospective communities of Surprise, Sun City and Chandler with state-of-the-art physical, occupational and speech rehabilitation centers designed by Sante Partners.

30 Nov 2010

Foot News and Research

BioMimetic granted Canadian notice of patent allowance covering rhPDGF-BB platform technology formulations

RAD to restore SCI's Radiation Treatment Center

Oxygen Biotherapeutics and SMP sign Binding Letter of Intent for joint chronic ischemic wound research

Study finds that immobilization devices significantly reduce braking response time

Synergetics launches next generation of Codman Malis electrosurgical generator

SunOpta subsidiary closes acquisition of Edner

Natural Prosthetic Dental Lab launches 'Digital revolution of dentistry'

Cannabis Science signs lease for new corporate headquarters in Denver, Colorado

ACCESS receives $6.7M NIH Clinical and Translational Science Award

Research programs embody the promise of anti-aging medicine.

MMI-USA announces limited launch of new Smart Toe II Hammertoe Fixation System

DPT granted FDA approval to manufacture Collagenase SANTYL Ointment for wound care

Researchers synthesize wound-healing peptides

32% of UAE residents could have diabetes or prediabetes by 2020

Third Edition of Occupational Medicine Practice Guidelines released

New brain imaging technique can trace effects of SYN115 drug in Parkinson's disease

Rush University enrolls first U.S. patient in international clinical trial for melanoma

Methodist to develop national training center for treatment of cardiovascular disease

University Hospitals receives $42 million for cancer care

Sante to break ground on second and third post hospital stay rehabilitation centers

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News